Navigation Links
Preventing the Next Virginia Tech -- The National Behavioral Intervention Team Association Launched Today
Date:1/15/2009

MALVERN, Pa., Jan. 15 /PRNewswire/ -- Today marked the launch of the National Behavioral Intervention Team Association (http://www.nabita.org).

NaBITA's mission: The National Behavioral Intervention Team Association (NaBITA) is committed to providing education, development and support to professionals in schools and in the workplace who endeavor every day to make their campuses and workplaces safer through caring prevention and intervention.

NaBITA is a state-of-the-art resource for protecting schools, colleges and workplaces from threats and violence. School shootings are ever more frequent. Workplace violence is commonplace. Yet, violence is often preventable. Those who intend to act with aggression frequently give signs and clues to what they are planning. In the wake of increasing shootings and violence across the country, behavioral intervention teams have been formed at thousands of schools, colleges and workplaces. These teams are the best chance we have of identifying individuals who are headed toward crisis, and averting that crisis.

As these teams have become rampantly popular, they have reached a point of critical mass. At such a point, an association is needed as a hub around which a new field can coalesce. That point is now. That hub is NaBITA (http://www.nabita.org).

NaBITA is an independent entity created by a team of mental health experts, prevention specialists, educators and attorneys who are well-known and respected in their professional circles. One of the creators, Brett A. Sokolow, Esq. of NCHERM (http://www.ncherm.org), was asked why he helped to found NaBITA. He replied, "Two years ago, our firm was a small law and consulting firm. The events of Virginia Tech catapulted our CUBIT behavioral interventi
'/>"/>

SOURCE National Behavioral Intervention Team Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Blood-flow detector software show promise in preventing brain damage
2. Preventing variceal bleeding
3. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
4. Preventing or reducing enlarged heart decreases risk of heart failure
5. Pill Equals Injection in Preventing Clots After Hip Replacement
6. Treating obstructive sleep apnea, preventing heart attacks and strokes
7. Preventing lung scarring may extend lives of lung cancer patients
8. Preventing or reducing enlarged heart may decrease risk for diabetes
9. Study shows drug effective in treating, preventing breast cancer
10. Good Hygiene Is Key to Preventing MRSA
11. Preventing Cancer, This Week on Your Cancer Today(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-USNewswire/--WhenmostpeopleheartheacronymTM...ivepatientsthehelptheyneed.TMJstandsfortheTemporal...acts/connectswithyourskull(temporalbone). ,, Th...painwithchewing,clickingorpoppingofthejaw.Butmanyo...:headaches,fatigue,sleepdisturbances,irritability,...
(Date:11/25/2009)...5/PRNewswire-FirstCall/-- OnyxPharmaceuticals,Inc...sttwoinvestoreventsinDecember: ,, ASHBriefing... ,, Principalinvestigatorswilldiscussdatapresen...ctorymultiplemyeloma,asfeaturedatthe51stAmericanSo...NewOrleans,LA.Theteleconferencewillbeginat9:00a.m....
(Date:11/25/2009)...re/-SentinelleMedicalInc.,aleadingmanufacturerofbr...esasuiteofnewleadingedgeclinicalapplicationsonitsA...RadiologicalSocietyofNorthAmerica(RSNA)annualmeeti...applicationsleveragetheuniquehighqualityimagesgene...pportmultipleimagingmodalitiesformulti-parametrica...
(Date:11/25/2009).../PRNewswire-USNewswire/--AnarticlebyJanetWoodcock,...esearch,titled"ADifficultBalance-PainManagement,Dr...TheNewEnglandJournalofMedicine. ,, (Logo: http:...,, Inthearticle,WoodcockdiscussesFDAeffortstost...honeeditandmanagingtherisksposedbyvariousanalgesic...
(Date:11/25/2009)...ewswire/--TheBayAreaAirQualityManagementDistrictis...Air Alert forThursday,November26,2009whichban...el,bothindoorsandoutdoors. ,, "Cold,stillweathe...JackBroadbent,executiveofficeroftheAirDistrict."We...neighborsandfellowcommunitymembersthisThanksgiving...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...ore research is being published showing the benefi...l tolerated by most patients due to the aftertaste...hers at Banner now say they have developed a chewa...oft chewable shell that can be taken without water...
... medications available , one must also be wary of ...ng to the Drug Control Department, 63 batches of s...killers and cardiac medicines, are being sold in B... drug racket first came to light in May-end this y...
...n B9 has been known to help in the brain developme...e to this reason it is administered to pregnant wo...ngen University, Netherlands has proposed that thi... increased levels of homocysteine. This amino acid...
... Lancet investigated the efficacy of acupuncture c...puncture in patients with osteoarthritis of the kn...reat many types of patients with chronic pain. ...o the acupuncture group, second group with 76 pati...
...able to stop the geriatric population from falling...ntain their balance. The device is called Yak...e that conforms to the footwear and helps the peop...of the number of falls they have on wearing the de...
...rom peripheral arterial disease may lose their lim...s to attend to them. Research findings report that...r surgeons, report less number of cases where pati...ften the only symptom experienced is a recurring p...
Other Medicine News:
(Date:11/25/2009)...ire-FirstCall/--Formanyofthemillionsofhearingimpai...ated hearingloss ,theholidaysmaynotbeallthathappy,...cepresidentofHearUSA(Amex: EAR ),oneofAmerica,slar...eshavelinkedhearinglosstostress,frustration,andsoc...gatheringswithfamiliesandfriends,whenmanyofthosewi...
(Date:11/25/2009)...tlinker.comannouncesthatanewmarketresearchreportis...DevicesMarketAnalysisandForecaststo2015 ,, ht...ental-Devices-Market-Analysis-and-Forecasts-to-201...sisandForecaststo2015 ,, Summary ,, Thisre...tarelatingtotheUSdentaldevicesmarket.Italsooffersd...
(Date:11/25/2009)...all/--NuVasive,Inc.(Nasdaq: NUVA ),amedicaldevicec...ptivesurgicaltreatmentsforthespine,announcedtodayt...09,at5:30p.m.ET/2:30p.m.PT.Theconferencecallwillfo...pany,sproductsandwillincludecommentsfrommanagement...nnumbersare1-877-407-4018fordomesticcallersand1-20...
Breaking Medicine Technology:For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3A Mediterranean Approach to Flavorful Living 56023 1A Mediterranean Approach to Flavorful Living 56023 2A Mediterranean Approach to Flavorful Living 56023 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 1Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 2Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 3Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off Label Marketing Practices 56020 4eDiets com Selects Karlin+Pimsler to Lead Creative Turnaround 56017 1eDiets com Selects Karlin+Pimsler to Lead Creative Turnaround 56017 2
...groups show dose-dependent PSA d... call to be held today at 8:30 A.M. Eastern time -...: MDVN ) today announced that its selective andro...ed serum levels of prostate specific,antigen (PSA)...rolled in,the first two dose groups of its ongoing...
...ustained virologic response in non-respond...results in line with previous studies of long-acti...th less frequent dosing -, - Final data from Phas..., Annual Meeting of the American Association for t... (AASLD) -, ROCKVILLE, Ma., Nov. 5 Human G...
Other Medicine Technology:Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 2Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 3Medivation's MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 2Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 3Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 4Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 5Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy 6
Hi-Top Post Op Shoe
EZY Close
Forefoot Reliever
Ultra 90 Fixed Plantar Fasciitis Splint
Medicine Products: